Measles and Mumps: Forgotten Diseases of Recurring Relevance

Overview

Over 6,000 mumps cases were reported in the US during 2016 by the CDC, the highest in a decade. While earlier routine vaccine programs drastically reduced rates of mumps and measles, these diseases have made a comeback – triggering the hunt for new strategies in effective drug development.

 Industry experts from Covance and Euroimmun will cover critical measles and mumps vaccination development issues including: 

  • Concomitant testing needs: any company developing pediatric vaccines for routine use will need to test for measles infection and protection during the clinical evaluation phase
  • How to measure immunity: examining the challenge of differentiating natural antibodies (from natural infection) from vaccine elicited ones
  • Immune profiling of human immune response: measles antibodies as components of serological panels to evaluate immune response before and after treatment

Don’t miss your chance to register for this webinar about the challenges you’ll need to overcome when designing vaccine programs for these resurgent diseases.

EVENT DATES

Feb 2018
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728    

all,
TBD

CONTACT

EVENT MANAGER
EVENT MARKETING
EXHIBITOR
ATTENDEE
SPEAKER
SPONSORSHIP

SIGN UP


More information from these suppliers
By Signing up you agree to User Agreement and Privacy Policy
I want to list my services

CO-LOCATED EVENTS

FUTURE EVENTS DATES

PAST EVENTS DATES